➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
McKesson
Johnson and Johnson
McKinsey
Express Scripts

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Albumin (human) - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for albumin (human)

Identify potential brand extensions & biosimilar entrants

SponsorPhase
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1
Assiut UniversityPhase 2
Kashif KhanPhase 2

See all albumin (human) clinical trials

Recent Litigation for albumin (human)

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.2019-08-08
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all albumin (human) litigation

PTAB Litigation
PetitionerDate
Apotex Inc.2017-11-09
Cipla Ltd.2017-11-09
Actavis LLC2017-04-04

See all albumin (human) litigation

Patent Text Search: US Patents for albumin (human)

These patents were identified by searching patent claims

Supplementary Protection Certificates for albumin (human)

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3 Finland   Start Trial
2009 00036 Denmark   Start Trial PRODUCT NAME: PACLITAXELALBUMIN
2014000065 Germany   Start Trial PRODUCT NAME: PACLITAXEL ALS AN ALBUMIN GEBUNDENE NANOPARTIKEL-FORMULIERUNG; REGISTRATION NO/DATE: K(2013)9835 20131220
/2014 Austria   Start Trial PRODUCT NAME: PACLITAXEL, DAS ALS ALBUMIN GEBUNDENE NANOPARTIKEL FORMUIERT IST.; REGISTRATION NO/DATE: EU/1/07/428 (MITTEILUNG) (GEAENDERT DURCH C(2013) 9835) 20131230
09C/046 Belgium   Start Trial PRODUCT NAME: PACLITAXEL ALBUMIN; AUTHORISATION NUMBER AND DATE: EU/1/07/428/001 20080111
613 Luxembourg   Start Trial 91613, EXPIRES: 20220924
1 Finland   Start Trial
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
Harvard Business School
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.